Staff turnover in EUR133,295160,223179,078177,951176,594
Staff turnover in EUR133,295160,223179,078177,951176,594
The share: stated in EUR20212022202320242025
Shares outstanding (in mn.)21.8521.8521.8521.8521.85
Dividend per share-----
Basic earnings per share-0.25-0.30-0.38-0.51-0.54
P/L in EUR million under IAS/IFRS20212022202320242025
Turnover38.449.555.354.649.6
Operating income (EBIT)-2.0-3.2-5.1-8.5-9.5
Earnings before taxes-2.6-3.7-6.0-10.5-11.5
Annual net profit/ loss-5.0-6.6-8.3-11.1-11.7
Balance sheet in EUR million under IAS/IFRS20212022202320242025
Assets
Total current assets39.130.425.545.725.0
Total fixed assets38.647.645.543.141.4
Total assets77.778.070.988.766.3
Liabilities
Total short-term liabilities11.321.417.525.017.6
Total long-term liabilities24.622.430.449.846.9
Total provisions2.31.20.90.90.7
Equity capital41.834.223.013.91.8
Total liabilities77.778.070.988.766.3
Management:
Adriaan Moelker
Michael Schneiders
Board:
Michael Majerus
Anna Carina Eichhorn
Florian Schnabel
Ursula La Cognata
Christine Uekert
Stephen Catling
Shareholding in %:
Daniel Hopp 5.60
Deka Investment GmbH 1.89
FPM Frankfurt Performance Management AG 1.65
Generali Investments LLC 0.17
Joh. Berenberg, Gossler & Co. KG (Investment Management) 0.20
KBC Asset Management NV 0.27
MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH 1.51
Martin Putsch 31.50
Pbg Zweite GmbH 15.10
Universal-Investment-Gesellschaft mbH (Invt Mgmt) 2.99
Freefloat 39.13
Address: Darmstädter Strasse 34-36, 64673 Zwingenberg
T: +49-6251-9331-0
F: +
I: http://www.brain-biotech.de
E: [email protected]